Skip to content

Integrative Analysis of CRC Liver Metastasis

Integrative Analysis of CRC Liver Metastasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02917707
Acronym
CRC-LM
Enrollment
1000
Registered
2016-09-28
Start date
2016-01-31
Completion date
2026-12-31
Last updated
2016-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastasis

Keywords

CRC, liver metastasis

Brief summary

The investigators will perform integrative analysis of CRC liver metastasis

Detailed description

The investigators will analyzed proteomes of paired normal colorectal tissues and colorectal cancer (CRC) with or without liver metastasis, sequenced transcriptomes, performed whole exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each comprising normal colorectal tissue, primary colorectal carcinoma, and its synchronous matched liver metastasis, as well as analyzed genomics of CRC characterized previously by The Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.

Interventions

OTHERnormal colorectal tissues

The investigators will extract total protein, DNA and RNA from these groups.

Sponsors

Ganzhou City People's Hospital
CollaboratorOTHER
Da Fu
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age ≤ 75 years with histologically proven CRC * No severe major organ dysfunction * WHO performance status of 0 or 1 * No prior cancer chemotherapy

Exclusion criteria

* Age ≥ 76 * Severe major organ dysfunction * World Health Organization (WHO) performance status of \>1 * Prior cancer chemotherapy

Design outcomes

Primary

MeasureTime frame
5 years overall survival5 years

Secondary

MeasureTime frame
5 years disease-free survival5 years

Countries

China

Contacts

Primary ContactDa Fu, Ph.D.
shsyiec@126.com021-66301604

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026